T. Ashmeade

发表

Evidence to Suggest that Agonist Modulation of Hyperlocomotion is Via Post-synaptic Dopamine D2 or D3 Receptors

C. Routledge, C. Reavill, L. Thorn, 1997, Neuropharmacology.

Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain.

J. Hagan, M. Duxon, J. Gartlon, 2004, European journal of pharmacology.

Central effects of urotensin-II following ICV administration in rats

J. Hagan, S. Douglas, G. Riley, 2001, Psychopharmacology.

Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity

J. Hagan, A. Hunter, N. Upton, 2000, Psychopharmacology.

High-performance liquid chromatography/tandem mass spectrometry assay for the determination of 1-methyl-4-phenyl pyridinium (MPP+) in brain tissue homogenates

M. Hows, D. Virley, Angela A Austin, 2004, Journal of Neuroscience Methods.

Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.

J. Hagan, D. Middlemiss, K. Thewlis, 2000, The Journal of pharmacology and experimental therapeutics.

Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

M. I. Smith, M L Evans, J. Hagan, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats

J. Hagan, H. Sarau, P. Murdock, 2004, Psychopharmacology.

Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat.

J. Hagan, D. Middlemiss, K. Thewlis, 2000, Journal of medicinal chemistry.

Characterisation of amyloid-induced inflammatory responses in the rat retina

J. Richardson, S. Bate, T. Chapman, 2011, Experimental Brain Research.

Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

J. Richardson, N. Upton, D. Sunter, 2007, Journal of Neuroinflammation.

Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?

C. Routledge, L. Thorn, T. Ashmeade, 1996, Biochemical Society transactions.